Characteristics and Predictors of Obstructive Sleep Apnea in Patients With Systemic Hypertension

American Journal of Cardiology

Volumn 105, Issue 8, 2010, Pages 1135-1139

  Drager, Luciano F ^a   Genta, Pedro R ^a   Pedrosa, Rodrigo P ^a   Nerbass, Flávia B ^a   Gonzaga, Carolina C ^b   Krieger, Eduardo M ^a   Lorenzi Filho, Geraldo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ANTIHYPERTENSIVE THERAPY; ARTICLE; BERLIN QUESTIONNAIRE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DYSLIPIDEMIA; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NECK; OBESITY; OXYGEN SATURATION; POLYSOMNOGRAPHY; PREDICTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SLEEP APNEA SYNDROME; SNORING; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; BLOOD PRESSURE; BODY MASS INDEX; BRAZIL; CIRCADIAN RHYTHM; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; POLYSOMNOGRAPHY; PREVALENCE; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SLEEP APNEA, OBSTRUCTIVE; YOUNG ADULT;

EID: 77950368432     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.12.017     Document Type: Article

References (24)

1. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., Roccella E.J., Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, and National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252
2. Sjöström C., Lindberg E., Elmasry A., Hägg A., Svärdsudd K., and Janson C. Prevalence of sleep apnoea and snoring in hypertensive men: a population based study. Thorax 57 (2002) 602-607
3. Logan A.G., Perlikowski S.M., Mente A., Tisler A., Tkacova R., Niroumand M., Leung R.S., and Bradley T.D. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19 (2001) 2271-2277
4. Drager L.F., Bortolotto L.A., Figueiredo A.C., Silva B.C., Krieger E.M., and Lorenzi-Filho G. Obstructive sleep apnea, hypertension and their interaction on arterial stiffness and heart remodeling. Chest 131 (2007) 1379-1386
5. Drager L.F., Bortolotto L.A., Krieger E.M., and Lorenzi-Filho G. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension 53 (2009) 64-69
6. Bradley T.D., and Floras J.S. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373 (2009) 82-93
7. Silverberg D.S., Oksenberg A., and Iaina A. Sleep related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated. Am J Hypertens 10 (1997) 1319-1325
8. Kapur V., Strohl K.P., Redline S., Iber C., O'Connor G., and Nieto J. Underdiagnosis of sleep apnea syndrome in U.S. communities. Sleep Breath 6 (2002) 49-54
9. Young T., Skatrud J., and Peppard P.E. Risk factors for obstructive sleep apnea in adults. JAMA 291 (2004) 2013-2016
10. Netzer N.C., Stoohs R.A., Netzer C.M., Clark K., and Strohl K.P. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131 (1999) 485-491
11. Calhoun D.A., Jones D., Textor S., Goff D.C., Murphy T.P., Toto R.D., White A., Cushman W.C., White W., Sica D., Ferdinand K., Giles T.D., Falkner B., and Carey R.M. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51 (2008) 1403-1419
12. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-559
13. Drager L.F., Bortolotto L.A., Lorenzi M.C., Figueiredo A.C., Krieger E.M., and Lorenzi-Filho G. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172 (2005) 613-618
14. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith Jr. S.C., Spertus J.A., Costa F., American Heart Association, National Heart, Lung, and and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112 (2005) 2735-2752 Erratum in: Circulation 2005;112:e297
15. Gus M., Gonçalves S.C., Martinez D., de Abreu Silva E.O., Moreira L.B., Fuchs S.C., and Fuchs F.D. Risk for obstructive sleep apnea by Berlin questionnaire, but not daytime sleepiness, is associated with resistant hypertension: a case-control study. Am J Hypertens 21 (2008) 832-835
16. Drager L.F., Queiroz E.L., Lopes H.F., Genta P.R., Krieger E.M., and Lorenzi-Filho G. Obstructive sleep apnea is highly prevalent and correlates with impaired glycemic control in consecutive patients with the metabolic syndrome. J Cardiometab Syndr 4 (2009) 89-95
17. Drager L.F., Bortolotto L.A., Maki-Nunes C., Trombetta I.C., Alves M.J., Fraga R.F., Negrão C.E., Krieger E.M., and Lorenzi-Filho G. The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome. Atherosclerosis 208 (2010) 490-495
18. Venkateswaran S., and Shankar P. The prevalence of syndrome Z (the interaction of obstructive sleep apnoea with the metabolic syndrome) in a teaching hospital in Singapore. Postgrad Med J 83 (2007) 329-331
19. Harsch I.A., Schahin S.P., Radespiel-Tröger M., Weintz O., Jahreiss H., Fuchs F.S., Wiest G.H., Hahn E.G., Lohmann T., Konturek P.C., and Ficker J.H. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169 (2004) 156-162
20. Chin K., Shimizu K., Nakamura T., Narai N., Masuzaki H., Ogawa Y., Mishima M., Nakamura T., Nakao K., and Ohi M. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100 (1999) 706-712
21. Peppard P.E., Young T., Palta M., and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
22. Li J., Savransky V., Nanayakkara A., Smith P.L., O'Donnell C.P., and Polotsky V.Y. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol 102 (2007) 557-663
23. Tan K.C., Chow W.S., Lam J.C., Lam B., Wong W.K., Tam S., and Ip M.S. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184 (2006) 377-382
24. Dorkova Z., Petrasova D., Molcanyiova A., Popovnakova M., and Tkacova R. Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134 (2008) 686-692